MGP
INDV icon

M&G plc’s Indivior Pharmaceuticals INDV Stock Holding History

M&G plc’s Portfolio INDV Stock Details INDV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-110,039
Closed -$1.41M – 459
2024
Q4 		$1.41M Hold
110,039
– – 0.01% 334
2024
Q3 		$108M Sell
110,039
-7,507
-6% -$87.9K 0.39% 48
2024
Q2 		$184M Hold
117,546
– – 0.73% 24
2024
Q1 		$251M Buy
+117,546
New +$2.21M 0.95% 13

Other funds holding INDV

TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return
OCM
Oaktree Capital Management Los Angeles, California $7.21B AUM 45.97% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.32B AUM 132.6% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

M&G plc's INDV Position: Q1 2025 in Review

M&G plc sold out of Indivior Pharmaceuticals (INDV) in Q1 2025, closing a stake of 110,039 shares — an estimated $1.41M sold.

M&G plc first reported a position in INDV in Q1 2024 and held it in 4 quarters. The position peaked at $251M in Q1 2024. 116 funds tracked by Wall St. Rank hold INDV as of Q1 2025.

  • M&G plc reported no remaining Indivior Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
  • M&G plc sold 110,039 Indivior Pharmaceuticals shares in Q1 2025, an estimated $1.41M.
  • M&G plc first reported a position in Indivior Pharmaceuticals in Q1 2024 and held it in 4 quarters.
  • M&G plc's Indivior Pharmaceuticals position peaked at $251M in Q1 2024.
  • 116 funds tracked by Wall St. Rank held Indivior Pharmaceuticals as of Q1 2025.

Based on M&G plc's 13F filing for Q1 2025, filed 13 May 2025.